RichardDDrakeMD

Pathology • Toledo, OH

Anatomic Pathology, Clinical Pathology, Pediatric Pathology

Physician

Join to view full profile

Are you Dr. Drake?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 29 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
2222 Cherry St
Toledo, OH 43608
Phone+1 419-251-4534
Is this information wrong?

Summary

Dr. Richard Drake, MD is a board certified pathologist in Toledo, Ohio. He is currently licensed to practice medicine in Ohio. He is affiliated with Mercy Health - St. Vincent Medical Center, Mercy St. Anne Hospital, and Cleveland Clinic.

Education & Training

Ohio State University HospitalResidency, Pathology-Anatomic and Clinical, 1984 - 1988
Western Michigan University Homer Stryker MD School of MedicineInternship, Transitional Year, 1983 - 1984
Indiana University School of MedicineClass of 1983

Certifications & Licensure

OH State Medical License 1987 - 2025
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Pathology Pediatric Pathology

Publications & Presentations

PubMed

32 citations
Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature.
Kristen D Starbuck, Richard D. Drake, G. Thomas Budd, Peter G. Rose> ;Anticancer Research. 2016 Nov 1
42 citations
A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA).
Fiona Simpkins, Richard D. Drake, Pedro F. Escobar, Benjamin Nutter, Nabila Rasool, Peter G. Rose> ;Gynecologic Oncology. 2015 Feb 1
16 citations
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube.
Thomas J. Herzog, Bradley J. Monk, Peter G. Rose, Patricia S. Braly, Jeffrey F. Hines, Maria C. Bell, Robert M. Wenham, Angeles Alvarez Secord, Lynda D. Roman, Mark H....> ;Gynecologic Oncology. 2014 Mar 1
20 citations
Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome.
Mark Lachiewicz, Sara E. Kravochuck, Margaret O'Malley, Brandie Heald, James M. Church, Matthew F. Kalady, Richard D. Drake> ;Gynecologic Oncology. 2014 Feb 1
66 citations
A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carci...
Don S. Dizon, John A. Blessing, Richard T. Penson, Richard D. Drake, Joan L. Walker, Carolyn Johnston, Paul DiSilvestro, Amanda Nickles Fader> ;Gynecologic Oncology. 2012 May 1
4 citations
Mural Nodules of Clear Cell Carcinoma in a Mucinous Borderline Tumor of the Ovary: A Case Report
Daniela S. Allende, Richard D. Drake, Longwen Chen> ;Pathology Research International. 2010 Apr 13
26 citations
A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecolog...
David Miller, John A. Blessing, Richard D. Drake, Robert V. Higgins, D. Scott McMeekin, Louis V. Puneky, Carolyn N. Krasner> ;Gynecologic Oncology. 2009 Dec 1
117 citations
Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma
Amanda N. Fader, Richard D. Drake, David M. O'Malley, Heidi E. Gibbons, Warner K. Huh, Laura J. Havrilesky, Paola A. Gehrig, Erin Tuller, Allison E. Axtell, Kristine M...> ;Cancer. 2009 May 15
62 citations
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.
Amanda N. Fader, Christa Nagel, Allison E. Axtell, Kristine M. Zanotti, Joseph L. Kelley, Kathleen N. Moore, Angeles Alvarez Secord, Christine Walsh, Warner K. Huh, Pa...> ;Gynecologic Oncology. 2009 Mar 1
Simplifying the preevacuation testing strategy for patients with molar pregnancy.
Lynne M. Knowles, Richard D. Drake, Raheela Ashfaq, Diego H. Castrillon, David Miller, John O. Schorge> ;The Journal of Reproductive Medicine. 2007 Aug 1
13 citations
Gestational trophoblastic disease among Hispanic women: A 21-year hospital-based study
Richard D. Drake, Gautam G. Rao, Donald D. McIntire, David Miller, John O. Schorge> ;Gynecologic Oncology. 2006 Oct 1
30 citations
Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Gautam G. Rao, Paula Rogers, Richard D. Drake, Phuc D. Nguyen, Robert L. Coleman> ;Gynecologic Oncology. 2005 Jan 1
38 citations
Oral dexamethasone attenuates Doxil-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies.
Richard D. Drake, W.Michael Lin, Melanie King, Diana Farrar, David Miller, Robert L. Coleman> ;Gynecologic Oncology. 2004 Aug 1
73 citations
Osteopontin as an Adjunct to CA125 in Detecting Recurrent Ovarian Cancer
John O. Schorge, Richard D. Drake, Hang Lee, Steven J. Skates, Ramababu Rajanbabu, David Miller, Jae Hoon Kim, Daniel W. Cramer, Ross S. Berkowitz, Samuel C. Mok> ;Clinical Cancer Research. 2004 May 15
Join now to see all

Hospital Affiliations

Mercy Health - St. Vincent Medical CenterToledo, Ohio
Mercy St. Anne HospitalToledo, Ohio
Cleveland ClinicCleveland, Ohio